Recent advances in understanding the mechanisms behind ICI treatment have allowed new treatment options such as abatacept and anti-TNFα agents that can reduce drug toxicity and allow continuation of treatment to achieve tumor clearance. The gene discussed is TNF; the disease is neoplasm.